Reebok Mens New AZTREK TAKSE 10.0 - 7.0 US ROSE / ROYAL / CHARLK CN7068 OG Athletic Shoes


  1. Home
  2. Reebok Mens New AZTREK TAKSE 10.0 - 7.0 US ROSE / ROYAL / CHARLK CN7068 OG
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
New Mens Reebok AZTREK OG CN7068 CHARLK / ROYAL / ROSE US 7.0 - 10.0 TAKSE
Condition: New with box: A brand-new, unused, and unworn item (including handmade items) in the original packaging (such as Style: Athletic Sneakers
Color:

White

Width: Medium (D, M)
Brand:

Reebok

Pattern: Solid







published on tue nov 09 2021

Reebok Mens New AZTREK TAKSE 10.0 - 7.0 US ROSE / ROYAL / CHARLK CN7068 OG Athletic Shoes

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Reebok Mens New AZTREK TAKSE 10.0 - 7.0 US ROSE / ROYAL / CHARLK CN7068 OG Athletic Shoes

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS